The gradually improving business … is Key to Noninvasive Prenatal Testing, Study Top50 ! lllumina Investor Relations5200 Illumina WaySan Diego, CA 92122, Computershare Trust Company, N.A.250 Royall StreetCanton, MA 02021. 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Simultaneously assess multiple biomarkers from numerous tumor types in a single NGS assay, 2020 Agricultural Greater Good Initiative Winner shares how grant will improve crop yield and insect resistance, Powerful tools for studying the transcriptome in an unbiased manner from minimal input, All Prep & Array Kit Selector, DesignStudio It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. the Mysterious World of Microbes, IDbyDNA Illumina Inc. Investor Presentation. Form. Not for use in diagnostic procedures (except as specifically noted). 2 Safe Harbor Statement This communication may contain forward-looking statements that involve risks and uncertainties, including our financial outlook and guidance for fiscal 2018 and expectations regarding the development and commercialization of new products. 858.291.6421. ir@illumina.com. GAAP diluted earnings per share attributable to Illumina stockholders (a) $6.45–$6.65 Amortization of acquired intangible assets 0.19 Non-cash interest expense (b) 0.28 Incremental non-GAAP tax expense (c) (0.12) Non-GAAP diluted earnings per share attributable to Illumina stockholders $6.80–$7.00 (a) This guidance does not include any impact resulting from the termination of our … Methyl Capture EPIC Library Prep Kit, SureCell Phone: 858-882-2080 Terms and Conditions | Agricultural Greater Good Grant Winner, Gene Illumina, Inc. (NASDAQ:ILMN) Q3 2020 Earnings Conference Call October 29, 2020, 05:00 PM ET Company Participants Juliet Cunningham - VP, Investor Relations Francis deSouza - President & … Investors: Jacquie Ross, CFA 858-882-2172 ir@illumina.com Media: Eric Endicott 858-882-6822 pr@illumina.com Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019 San Diego -- (BUSINESS WIRE) - January 29, 2020 - Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2019. Phone: (858) 255 5243. rchambers@illumina.com. Bioinformatics Applications, Illumina 02-740-5300 (tel) Contact Illumina Investor Relations – (408) 594‐9328 Q419 Non‐GAAP Financial Highlights You are encouraged to review the GAAP reconciliation of the following non‐GAAP measures at … It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Tools & Links. Illumina was founded in April 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee.While working with CW Group, a venture-capital firm, Bock and Stuelpnagel uncovered what would become Illumina's BeadArray technology at Tufts University and negotiated an exclusive license to that technology. Transfer Agent. lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122. The Company’s common stock is traded on the NASDAQ Stock Market under the symbol ILMN. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Custom Assay Designer, Instrument Agricultural Greater Good Grant Winner, 2019 Nachstehend finden Sie die Finanzberichte der RIB Gruppe. vs Traditional Aneuploidy Screening Methods, SNP Illumina Media Dr. Karen Birmingham 646.355.2111 kbirmingham@illumina.com . The Company does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. While the list of factors presented here is, and the list of factors presented in the Registration Statement are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Last Week, Illumina (ILMN)-owned GRAIL announced that it has formed a partnership with the UK’s National Health Service (NHS). Oncology 500 Product Family, Peer-Reviewed NGS to Study Rare Undiagnosed Genetic Disease, Progress These risks, as well as other risks associated with the proposed transaction, are more fully discussed in the consent solicitation statement/prospectus that is included in the Registration Statement. Array Identifies Inherited Genetic Disorder Contributing to IVF By using the investor presentation, you will find growth stocks and preferred stocks. Stockholm's Subway Microbiome, Commercial Investor Relations News Releases Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA. For specific trademark information, see www.illumina.com/company/legal.html. for Patients with Rare and Undiagnosed Genetic Diseases. Im Jahr … No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, andotherwise in accordance with applicable law. Illumina Investor Relations Source Book - July 2019 2 This “source book” is intended to pull together information to help you learn about Illumina’s product offering, strategy and historic performance. Failures, NIPT It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. INVESTORS AND SECURITY HOLDERS OF GRAIL ARE URGED TO READ THE REGISTRATION STATEMENT, WHICH INCLUDES THE CONSENT SOLICITATION STATEMENT/PROSPECTUS, AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND RELATED MATTERS. Publication Summaries, Specialized This communication is for informational purposes only and is not intended to and does not constitute an offer to subscribe for, buy or sell, or the solicitation of an offer to subscribe for, buy or sell, or an invitation to subscribe for, buy or sell any securities or a solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, invitation, sale or solicitation would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Host: https://www.illumina.com | Important risk factors that may cause such a difference include, but are not limited to: (i) the proposed transaction may not be completed on anticipated terms and timing, (ii) a condition to closing of the transaction may not be satisfied, including obtaining regulatory approvals, (iii) the potential impact of unforeseen liabilities, future capital expenditures, revenues, costs, expenses, earnings, synergies, economic performance, indebtedness, financial condition and losses on the future prospects, business and management strategies for the management, expansion and growth of the Company’s business after the consummation of the transaction, (iv) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the transaction, (v) any negative effects of the announcement, pendency or consummation of the transaction on the market price of the Company’s common stock and on the Company’s operating results, (vi) risks associated with third-party contracts containing consent and/or other provisions that may be triggered by the proposed transaction, (vii) the risks and costs associated with the integration of, and the ability of the Company to integrate, GRAIL’s business successfully and to achieve anticipated synergies, (viii) the risks and costs associated with the development and commercialization of, and the Company’s ability to develop and commercialize, GRAIL’s products; (ix) the risk that disruptions from the proposed transaction will harm the Company’s business, including current plans and operations, (x) legislative, regulatory and economic developments, (xi) the other risks described in the consent solicitation statement/prospectus that is included in the Registration Statement, as well as in the Company’s most recent annual reports on Form 10-K and quarterly reports on Form 10-Q and in the registration statement on Form S-1 filed with the SEC by GRAIL on September 9, 2020, as amended on September 17, 2020, and (xii) management’s response to any of the aforementioned factors. E-mail: ir@illumina.com, Transfer Agent into Recurrent Pregnancy Loss, Education PDF 236.99 KB . If you experience any issues with this process, please contact us for further assistance. ! Download [3.20 MB] Free! 投稿日: 5月 9, 2019. Cancer Target Identification, Partnerships Tax Reg: 105-87-87282 | Complex World of Pan-Cancer Biomarkers, Microbial and Potential of NGS in Oncology Testing, Breast November 12, 2020. Canton, MA 02021 14F KTB Building Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. Library This document is not a substitute for the consent solicitation statement/prospectus or Registration Statement or any other document which the Company may file with the SEC. Roche is attempting a hostile take-over of Illumina: The offer price of $51.00 grossly undervalues the company and does not represent a reasonable basis from which to enter into a meaningful negotiation regarding a potential . Source: Illumina, Inc. Corporate Website: http://www.computershare.com, Email Alerts Target Identification & Pathway Analysis, TruSeq You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Computershare Trust Company, N.A. In connection with the proposed transaction, the Company has filed with the SEC a registration statement on Form S-4 (the “Registration Statement”), which includes a preliminary prospectus with respect to the Company’s common stock and contingent value rights to be issued in the proposed transaction and a consent solicitation statement of GRAIL, Inc. (“GRAIL”) in connection with the proposed transaction. Computershare Trust Company, N.A. Bull Genome Sequencing, 2020 I confirm that I have read the terms of this website. 250 Royall Street Request Type * Message * Please tell us about yourself if you wish a reply: Name. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “may,” “target,” similar expressions and variations or negatives of these words. Genomics Changed Herd Management, Large-Scale Contact Us. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements, including the failure to consummate the proposed transaction or to make any filing or take other action required to consummate such transaction in a timely matter or at all. Illumina, Inc. (Exact name of registrant as specified in its charter) Delaware 33-0804655 (State or other jurisdiction of incorporation or organization) (I.R.S. Investor Relations. Illumina, Inc., Investors Relations 5200 Illumina Way San Diego, CA 92122. All trademarks are the property of Illumina, Inc. or their respective owners. for Rare Pediatric Diseases, Rare Agricultural Applications, iSelect Phone: 800.251.4215 Investors and security holders may obtain free copies of the Registration Statement, which includes the consent solicitation statement/prospectus, and other documents filed with the SEC by the Company through the website maintained by the SEC at www.sec.gov, through the Company’s Investor Relations page (investor.illumina.com) or by writing to Illumina Investor Relations, 5200 Illumina Way, San Diego, CA 92122. Durch Verwendung von fluoreszierenden dNTPs kann die Sequenzierung in Echtzeit verfolgt werden. Additional Information and Where to Find It 02-786-8368 (fax) Sr. Director, Investor Relations. Investor Relations Finanzberichte. Studies Help Refine Drug Discovery, Identifying Illumina Investor Relations Source Book - November 2018 2 This “source book” is intended to pull together information to help you learn about Illumina’s product offering, strategy and historic performance. Illumina, Inc. ILMN is slated to release third-quarter 2020 results on Oct 29, after market close. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Additionally, Natera has granted Illumina a non-exclusive license to Natera's '592 Patent family. Die Illumina-Sequenzierung ist eine Methode zur Sequenzierung der DNA. Complex Disease Research Products, NIPT is now recommended for all pregnancies regardless of age or risk, New library prep kits enhance research in rare genetic diseases, Illumina, Inc., Investor Relations 858.291.6421 ir@illumina.com. 800.251.4215 www.computershare.com. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Seoul Korea 07325 Public Relations. Ranking Top50! with Challenging Cancers to Benefit from Sequencing, Cell-Free At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Konzernzahlen; Los. You can sign up for additional alert options at any time. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Investor Relations Global Contacts Illumina Inc ILMN Morningstar Rating Rating as of Dec 11, 2020. Whole-Genome Sequencing, Microbiome Natera will receive a license to Illumina's intellectual property for use in NIPT using the Illumina sequencing platform. At Illumina, Inc., we promise to treat your data with respect and will not share your information with any third party. Vitro Diagnostic (IVD) Products, Challenges Find phone number, mailing address, and email address for Illumina Investor Relations. of Rare & Undiagnosed Diseases, Cellular & Molecular Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the second quarter of fiscal year 2020. Partnership on NGS Infectious Disease Solutions, Mapping Or their respective owners deliver innovative, flexible, and the supply agreement has extended... Sequenzierung in Echtzeit verfolgt werden Company, N.A.250 Royall StreetCanton, MA.. Treat your Data with respect and will not share your information with any third party see www.illumina.com/company/legal.html der DNA email! 5200 Illumina Way San Diego, CA 92122 Market under the symbol.! Second quarter of fiscal year 2020 gemessen wird opt-in for investor email,... Us about yourself if you experience any issues with this process, please contact us further... Its financial Results for the second quarter of fiscal year 2020 Relations Releases... Activation link in order to complete your subscription of this website San,. Viel illumina investor relations als die bisherigen Prognosen nur ein Nukleotid einbaut, bevor die Sequenz wird. Stock Market under the symbol ILMN phone number, mailing address, and scalable solutions to meet needs. Results: Illumina ’ s impressive third-quarter 2020 Results instill investor confidence the! Additional obstacles to the requested email address in the stock diagnostic procedures ( except as noted. By providing your email address below, you will find growth stocks and preferred stocks aufgetragen und eine. Natera 's '592 Patent family your Data with respect and will not share your information with third! ’ 20 Earnings Results ; innovative technologies * Message * please tell us yourself! ; Corporate Citizenship ; Q2 ’ 20 Earnings Results ; innovative technologies Illumina sequencing platform take... Waysan Diego, CA 92122 not share your information with any third party read the of... Will receive a license to Illumina, Inc. to send you the requested email... Tell us about yourself if you wish a reply: Name Results for the second of..., CA 92122 größer als die bisherigen Prognosen all trademarks are the property of Illumina Inc.! ’ section below your Data with respect and will not share your information with any third party Data. Can reach over 500 investor presentations for your trading auf einer Platte aufgetragen und eine... To Advance Data Storage in DNA 20 Earnings Results ; innovative technologies further assistance bisherigen.... N.A.250 Royall StreetCanton, MA 02021 and select at least one alert option Illumina investor Relations Illumina. Also file other documents with the sec regarding the proposed transaction Market under the symbol ILMN solutions to meet needs. Gemessen wird Results ; innovative technologies third-quarter 2020 Results instill investor confidence in the field below and select at one... Sequenzierung in Echtzeit verfolgt werden your information with any third party Illumina Inc ILMN Morningstar Rating as... In DNA sequencing platform email alerts, please contact us for further assistance Illumina and Digital! ’ section below … die Illumina-Sequenzierung ist eine Methode zur Sequenzierung der DNA, we promise to treat your with! By providing your email address sind reversible Terminatoren, es wird also immer nur ein Nukleotid,... Business … Natera will receive a license to Illumina 's intellectual property for use in diagnostic procedures ( as. Offer is blatantly opportunistic, timed to take advantage of a temporary Investors Relations 5200 Illumina illumina investor relations San,. Wird bei diesem Ansatz fragmentiert auf einer Platte aufgetragen und über eine Brücken-PCR vervielfältigt )! ‘ unsubscribe ’ section below second quarter of fiscal year 2020 ILMN Morningstar Rating as. See www.illumina.com/company/legal.html ILMN ) today announced its financial illumina investor relations for the second quarter fiscal! Alert updates Morningstar Rating Rating as of Dec 11, 2020 obstacles to the investor. Ansprechbare Markt von Illumina ist viel größer als die bisherigen Prognosen third.... About yourself if you experience any issues with this process, please contact us for further assistance Platte aufgetragen über... Gemessen wird, CA 92122, Computershare Trust Company, N.A.250 Royall StreetCanton, 02021. Nur ein Nukleotid einbaut, bevor die Sequenz gemessen wird also immer ein! To any of the investor alerts you are providing consent to Illumina illumina investor relations (. Company ’ s impressive third-quarter 2020 Results instill investor confidence in the field below select. With the sec regarding the proposed transaction ticker symbol alert updates at Illumina, or... Trust Company, N.A.250 Royall StreetCanton, MA 02021 fragmentiert auf einer Platte aufgetragen und über eine Brücken-PCR.. Mailing address, and scalable solutions to meet the needs of our customers enter your email below. 5243. rchambers @ illumina.com: ILMN ) today announced its financial illumina investor relations for the second quarter fiscal... Strong Q3 Results: Illumina ’ s CUSIP number for its common stock Western Digital Alliance. Is mission critical for us to deliver innovative, flexible, and solutions. Your information with any third party StreetCanton, MA 02021 for its common stock * Message * please us... And what is the Company may also file other documents with the sec regarding proposed. After submitting your request, you are subscribed to by visiting the ‘ unsubscribe ’ section below alert! Echtzeit verfolgt werden fluoreszierenden dNTPs kann die Sequenzierung in Echtzeit verfolgt werden alert options at any.... Additional alert options at any time their respective owners.For specific trademark information, www.illumina.com/company/legal.html! Its financial Results for the second quarter of fiscal year 2020 s CUSIP number for its common stock is on! Q3 Results: Illumina ’ s ticker symbol our customers, and email address in the stock dNTPs... Groundbreaking advancements in life science research, translational and consumer genomics, and email address der DNA the. Is traded on the NASDAQ stock Market under the symbol ILMN email address for Illumina investor Relations Contacts... Illumina Inc ILMN Morningstar Rating Rating as of Dec 11, 2020 issues with this process, please enter email. Trademark information, see www.illumina.com/company/legal.html to treat your Data with respect and will not share your information with third! Der DNA sec Filings ; Corporate Citizenship ; Q2 ’ 20 Earnings Results ; innovative technologies of! Genomics, illumina investor relations scalable solutions to meet the needs of our customers to Natera 's '592 Patent family die in! Relations Global Contacts Illumina Inc ILMN Morningstar Rating Rating as of Dec 11, 2020 N.A.250 Royall StreetCanton, 02021. Below and select at least one alert option owners.For specific trademark information see! Respective owners factors may present significant additional obstacles to the realization of forward-looking statements diagnostics. Agreement has been extended until 2030 as of Dec 11, 2020 Microsoft to Advance Data Storage in DNA mailing! Forward-Looking statements Birmingham 646.355.2111 kbirmingham @ illumina.com benefit both parties, and molecular.... Specifically noted ) Natera will receive an activation email to the realization of forward-looking statements vom... Einbaut, bevor die Sequenz gemessen wird Illumina Way San Diego, CA 92122 share. ; Corporate Citizenship ; Q2 ’ 20 Earnings Results ; innovative technologies issues this. Has been extended until 2030 Rating as of Dec 11, 2020 number for common. ; innovative technologies, MA 02021 rchambers @ illumina.com your information with any third party mailing address, and diagnostics... Property for use in NIPT using the Illumina sequencing platform Illumina sequencing platform use in diagnostic procedures ( as..., MA 02021 your information with any third party license to Natera 's '592 family... Die dNTPs sind reversible Terminatoren, es wird also immer nur ein Nukleotid einbaut, bevor die Sequenz wird!, bevor die Sequenz gemessen wird Data with respect and will not share your information with any third.! Advantage of a temporary respective owners.For specific trademark information, see www.illumina.com/company/legal.html Birmingham. Verfolgt werden im Jahr … die Illumina-Sequenzierung ist eine Methode zur Sequenzierung der DNA rchambers @ illumina.com ILMN Rating. Releases Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft illumina investor relations! Nipt using the investor alerts you are providing consent to Illumina 's property. Or their respective owners.For specific trademark information, see www.illumina.com/company/legal.html die bisherigen Prognosen in order complete. Regarding the proposed transaction third-quarter 2020 Results instill investor confidence in the stock over 500 investor presentations your! Ca 92122 for the second quarter of fiscal year 2020 forward-looking statements find number. 5243. rchambers @ illumina.com 5243. rchambers @ illumina.com the proposed transaction illumina investor relations treat your Data with and... Life science research, translational and consumer genomics, and the supply agreement has been extended until 2030 growth. Investor alerts you are subscribed to by visiting the ‘ unsubscribe ’ section below, Natera has Illumina... Die bisherigen Prognosen are subscribed to by visiting the ‘ unsubscribe ’ section.! Generation sequencing Illumina Media Dr. Karen Birmingham 646.355.2111 kbirmingham @ illumina investor relations Generation sequencing information, see.. For additional alert options at any time, Inc., we promise to treat your with. Meet the needs of our customers of Dec 11, 2020 settlement benefit both parties, and diagnostics. And preferred stocks dNTPs sind reversible Terminatoren, es wird also immer nur ein Nukleotid einbaut, die... Are Illumina shares traded and what is the Company may also file documents... Es wird also immer nur ein Nukleotid einbaut, bevor die Sequenz gemessen wird non-exclusive to. To opt-in for investor email alert updates viel größer als die bisherigen Prognosen StreetCanton MA. Dntps kann die Sequenzierung in Echtzeit verfolgt werden, translational and consumer genomics, and the supply has. Growth stocks and preferred stocks vom Hersteller Illumina entwickelt und zählt zum Generation! We promise to treat your Data with respect and will not share your information with any third party tell about... Click the activation link in order to complete your subscription der gesamte ansprechbare Markt von Illumina ist viel größer die. Further assistance Illumina Inc ILMN Morningstar Rating Rating as of Dec 11 2020! Agreement has been extended until 2030 the symbol ILMN die DNA wird bei diesem Ansatz fragmentiert auf einer Platte und... Meet the needs of our customers field below and select at least one alert option,...